Reiko Sakurai
Maebashi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
A phase I study of S-1 and cisplatin with concurrent hypofractionated carbon-ion radiotherapy for patients with stage III non-small cell lung cancer.
Journal: Frontiers in oncology
Published: February 09, 2025
A Case of Primary Lung Adenocarcinoma With Recurrent Brain Metastasis due to Transformation to Small Cell Carcinoma During Adjuvant Atezolizumab Therapy.
Journal: Thoracic cancer
Published: September 10, 2024
Prognosis of non-small cell lung cancer with postoperative regional lymph node recurrence.
Journal: Thoracic cancer
Published: January 03, 2024
Role of Epiregulin in Lung Tumorigenesis and Therapeutic Resistance.
Journal: Cancers
Published: December 23, 2023
A case of autoimmune pulmonary alveolar proteinosis during the course of treatment of rapidly progressive interstitial pneumonia associated with anti-MDA5 antibody-positive dermatomyositis.
Journal: BMC pulmonary medicine
Published: December 17, 2023
Sustained antitumor response to lenvatinib with weekend-off and alternate-day administration in chemotherapy-refractory thymic carcinoma: a case report.
Journal: Anti-cancer drugs
Published: February 02, 2023
Durable response to afatinib rechallenge in a long-term survivor of non-small cell lung cancer harboring EGFR L858R and L747V mutations.
Journal: Thoracic cancer
Published: September 08, 2022
Role of Neuron-Specific Enolase in the Diagnosis and Disease Monitoring of Sarcoidosis.
Journal: Canadian respiratory journal
Published: December 27, 2021
Proposal for Reduction Measures of Eye Lens Exposure Based on Actual Exposure Management in Radiation-exposed Medical Staff
Journal: Nihon Hoshasen Gijutsu Gakkai zasshi
Published: February 22, 2021
Phase II Study of Weekly Nanoparticle Albumin-Bound Paclitaxel as Second- or Third-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer.
Journal: Chemotherapy
Published: January 21, 2020
Administration of docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte colony-stimulating factor for pretreated non-small cell lung cancer: a phase II study.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: October 07, 2019
Last Updated: 09/26/2026